Table 10.
CD8 + and interleukin-2 and −10 count values (n6)
| Baseline counts | |||||
|---|---|---|---|---|---|
| Subsets |
MED |
LQ |
UQ |
MIN |
MAX |
| CD 8 |
715 |
513.5 |
904.5 |
266 |
1373 |
| IL-2 |
7.18 |
5.85 |
8.5 |
4.51 |
9.14 |
| IL-10 |
136.22 |
30.04 |
214.39 |
0 |
234.86 |
|
Difference in counts after CLA treatment | |||||
| Subsets |
MED |
LQ |
UQ |
MIN |
MAX |
| CD 8 |
45 |
−35.5 |
275 |
−334 |
832 |
| IL-2 |
0.73 |
−1.16 |
1.72 |
−3.21 |
5.21 |
| IL-10 |
4.31 |
−76.74 |
62.57 |
−211.63 |
181.03 |
|
Difference in counts after HOSF treatment |
|
||||
| Subsets |
MED |
LQ |
UQ |
MIN |
MAX |
| CD 8 |
16.5 |
−261.5 |
155.5 |
−470 |
227 |
| IL-2 |
−0.74 |
−7.16 |
1.01 |
−10.36 |
5.21 |
| IL-10 |
54.27 |
−77.79 |
352.93 |
−125.04 |
615.78 |
|
Difference in counts between CLA and HOSF treatments | |||||
| Subsets |
MED |
LQ |
UQ |
MIN |
MAX |
| CD 8 |
290.5 |
−103.5 |
454 |
−439 |
644 |
| IL-2 |
1.85 |
−2.86 |
6 |
−4.22 |
15.57 |
| IL-10 |
−46.05 |
−564.56 |
138.28 |
−579.81 |
187.61 |
|
Difference in counts between baselines and end of the trial | |||||
| Subsets |
MED |
LQ |
UQ |
MIN |
MAX |
| CD 8 |
270 |
209.5 |
395 |
−118 |
1327 |
| IL-2 |
−2.45 |
−5.85 |
20.07 |
−7.01 |
144.39 |
| IL-10 | 107.82 | 82.39 | 521.35 | 66.33 | 1011.57 |
MAX: maximum MED: median; MIN: Minimum; LQ: lower quartile; UQ: upper quartile.